首页|人血白蛋白临床应用管理中国专家共识

人血白蛋白临床应用管理中国专家共识

扫码查看
人血白蛋白是从健康人的血液中提取分离的一种血液制品,在临床救治危急、重症患者中广泛应用。人血白蛋白临床超药品说明书用药及不合理用药现象均较为普遍,药物资源严重浪费。目前我国缺乏权威的指南或共识规范人血白蛋白临床应用管理。为了规范人血白蛋白合理用药管理措施,为人血白蛋白的临床合理应用提供指导,中国药学会医院药学专业委员会组织多学科专家,围绕供应管理、制订临床应用标准、超药品说明书用药管理、合理用药培训、处方环节管理、处方点评管理、信息化管理、患者用药科普等8个方面制订本共识。
Expert consensus on clinical application management of human albumin
Derived from healthy human blood,human albumin is widely applied for treating critically and seriously ill patients.However,inappropriate off-label and irrational use of human albumin has remained prevalent,resulting in significant wasting of valuable drug resources.Currently,there is an acute dearth of authoritative guidelines or consensus on clinical application manage-ment of human albumin in China.To address this wide gap,a multidisciplinary panel of experts,under the auspices of Committee of Hospital Pharmacy of Chinese Pharmaceutical Association,has collaborated on developing a comprehensive consensus for stan-dardizing management measures and providing guidance for rational utilization of human albumin.This consensus focused upon eight major aspects of clinical application management,including supply management,formulating clinical application standards,management of off-label drug use,training in rational usage,management of prescription sessions,prescription review processes,informatization management and patient education regarding medication usage.

human albuminrational utilizationexpert consensus

中国药学会医院药学专业委员会、《人血白蛋白临床应用管理中国专家共识》编写组、张玉

展开 >

华中科技大学同济医学院附属协和医院,湖北省重大疾病精准用药临床医学研究中心(武汉,430022)

人血白蛋白 合理应用 专家共识

国家重点研发计划

2023YFF1205003

2024

中国医院药学杂志
中国药学会

中国医院药学杂志

CSTPCD北大核心
影响因子:1.198
ISSN:1001-5213
年,卷(期):2024.44(7)
  • 108